Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

Circulation

Volumn 103, Issue 21, 2001, Pages 2531-2534

  Pasceri, Vincenzo ^b,c   Chang, Jed ^a   Willerson, James T ^b,c   Yeh, Edward T H ^a,b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Atherosclerosis; Cell adhesion molecules; Endothelium

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CHEMOKINE; CIGLITAZONE; FENOFIBRATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RANTES; RECOMBINANT CYTOKINE; SIMVASTATIN; TROGLITAZONE; UNCLASSIFIED DRUG; WY 14649;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; UMBILICAL VEIN;

EID: 0035967470     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.21.2531     Document Type: Article

References (26)

1. Circulating markers of inflammation for vascular risk prediction: Are they ready for prime time?
2. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
3. Direct proinflammatory effect of C-reactive protein on human endothelial cells
4. Chemokines and atherosclerosis
5. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase
6. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
7. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
8. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
9. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: Relationship with age, sex, and hormone replacement treatment
10. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas
11. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
12. Elevated levels of c-reactive protein at discharge in patients with unstable angina predict recurrent instability
13. Independent prognostic value of elevated C-reactive protein in unstable angina
14. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
15. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
16. Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13
17. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The cholesterol and recurrent events (CARE) investigators
18. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
19. Inhibition of monocyte chemotactic protein-1 synthesis by statins
20. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
21. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
22. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction
23. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
24. Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells
25. Δ12.14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
26. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1